Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 25, 2026
Silmitasertib, an FDA-designated orphan CK2 inhibitor, ameliorates neuropathology and motor dysfunction in a Huntington's disease mouse modelRoss J Pelzel, Miaya Herbst, Nicholas B Rozema, et al.Biorxiv : the Preprint Server for Biology|December 3, 2025
Silmitasertib, an FDA-designated orphan CK2 Inhibitor, ameliorates neuropathology and motor dysfunction in a Huntington's disease mouse modelRoss J Pelzel, Miaya A Herbst, Nicholas B Rozema, et al.Biorxiv : the Preprint Server for Biology|October 28, 2024
Enhanced Hippocampal Spare Capacity in Q175DN Mice Despite Elevated mHTT AggregationMelissa A Solem, Ross Pelzel, Nicholas B Rozema, et al.Journal of Huntington'S Disease|February 20, 2025
Absence of hippocampal pathology persists in the Q175DN mouse model of Huntington's disease despite elevated HTT aggregationMelissa A Solem, Ross G Pelzel, Nicholas B Rozema, et al.Pageof 1